These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34054516)

  • 1. Three Selected Edible Crops of the Genus
    Muronga M; Quispe C; Tshikhudo PP; Msagati TAM; Mudau FN; Martorell M; Salehi B; Abdull Razis AF; Sunusi U; Kamal RM; Sharifi-Rad J
    Front Pharmacol; 2021; 12():625546. PubMed ID: 34054516
    [No Abstract]   [Full Text] [Related]  

  • 2. First Report of Pseudoperonospora cubensis Causing Downy Mildew on Momordica balsamina and M. charantia in North Carolina.
    Wallace E; Adams M; Ivors K; Ojiambo PS; Quesada-Ocampo LM
    Plant Dis; 2014 Sep; 98(9):1279. PubMed ID: 30699625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Diversity of Medico-Magic Knowledge on Four Herbaceous Species in Benin.
    Dossou-Yovo HO; Kindomihou V; Vodouhè FG; Sinsin B
    ScientificWorldJournal; 2021; 2021():6650704. PubMed ID: 34194288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytomedicinal relevance of South African Cucurbitaceae species and their safety assessment: A review.
    Omokhua-Uyi AG; Van Staden J
    J Ethnopharmacol; 2020 Sep; 259():112967. PubMed ID: 32422356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Momordica balsamina: a medicinal and neutraceutical plant for health care management.
    Thakur GS; Bag M; Sanodiya BS; Bhadouriya P; Debnath M; Prasad GB; Bisen PS
    Curr Pharm Biotechnol; 2009 Nov; 10(7):667-82. PubMed ID: 19751180
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ramalhete C; Gonçalves BMF; Barbosa F; Duarte N; Ferreira MU
    Phytochem Rev; 2022; 21(2):617-646. PubMed ID: 35153639
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Bortolotti M; Mercatelli D; Polito L
    Front Pharmacol; 2019; 10():486. PubMed ID: 31139079
    [No Abstract]   [Full Text] [Related]  

  • 9. Bitter Melon (
    Sur S; Ray RB
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on the traditional uses, nutritive importance, pharmacognostic features, phytochemicals, and pharmacology of
    Mohammed FS; Babu D; Irfan Z; Fayed MAA
    PeerJ; 2024; 12():e16928. PubMed ID: 38436002
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
    Fang EF; Froetscher L; Scheibye-Knudsen M; Bohr VA; Wong JH; Ng TB
    Curr Protein Pept Sci; 2019; 20(3):296-301. PubMed ID: 29932035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Bioactive Metabolites, Antinutrients, and Bioactivities of African Pumpkin Leaves (
    Mashiane P; Shoko T; Manhivi V; Slabbert R; Sultanbawa Y; Sivakumar D
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335263
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Çiçek SS
    Front Pharmacol; 2022; 13():904643. PubMed ID: 35656300
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolomics and Molecular Networking to Characterize the Chemical Space of Four
    Ramabulana AT; Petras D; Madala NE; Tugizimana F
    Metabolites; 2021 Nov; 11(11):. PubMed ID: 34822421
    [No Abstract]   [Full Text] [Related]  

  • 15. Variation of Mineral Composition in Different Fruit Parts of Bitter Gourd (Momordica charantia L.).
    Singla D; Sangha MK; Singh M; Pathak M; Bala M
    Biol Trace Elem Res; 2023 Oct; 201(10):4961-4971. PubMed ID: 36626030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of cucurbitane-type triterpenes and triterpene glycosides in dietary supplements containing bitter melon (Momordica charantia) by HPLC-MS/MS.
    Ma J; Krynitsky AJ; Grundel E; Rader JI
    J AOAC Int; 2012; 95(6):1597-608. PubMed ID: 23451374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bitter melon: a panacea for inflammation and cancer.
    Dandawate PR; Subramaniam D; Padhye SB; Anant S
    Chin J Nat Med; 2016 Feb; 14(2):81-100. PubMed ID: 26968675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitane-Type Triterpenoids from the Blood Glucose-Lowering Extracts of
    Kaushik U; Aeri V; Showkat RM; Ali M
    Pharmacogn Mag; 2017 Jan; 13(Suppl 1):S115-S121. PubMed ID: 28479735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.
    Zhou S; Allard PM; Wolfrum C; Ke C; Tang C; Ye Y; Wolfender JL
    Metabolomics; 2019 Jul; 15(8):104. PubMed ID: 31321563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.